Revolution Medicines CEO Dr. Mark Goldsmith discusses the clinical trial results from Rasonque on ‘FBN’s Wall Street.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #fbnswallstreet #markgoldsmith #goldsmith #revolutionmedicines #rasonque #cancer #cancertreatment #clinicaltrial #biotech #biotechnology #healthcare #medicalresearch #medicine #pharmaceuticals #investing
Climbing borrowing costs have become a headache for Treasury Secretary Scott Bessent. But the United States is not the only country grappling with the potentially destabilizing consequences of soaring government debt.
A mom who started a new career in her 40s. An uncle who was moved to tears by an eclipse. Intimate obituaries, in 150 words or less.
A young father lost faith in his country’s defining idea and began to share his frustrations on social media. He found an eager audience.
Gen. Christopher T. Donahue’s vision for fighting future wars won him powerful supporters around the world. Could they save his career?
More than 120 people were arrested at a Memphis cantina, in one of the biggest immigration operations in Tennessee this year.
The president’s strategy, message and spending have left the G.O.P. in a difficult spot as lawmakers try to outrun his sagging approval ratings.
From Oregon to Florida, officials are at once reassuring voters that their ballots are safe and encouraging them to use drop boxes or vote in person.
The state has not elected a Republican to the Senate since 2010. But Chris Pappas, the likely Democratic nominee, anticipates a tough race against a well-known opponent, John E. Sununu.
The U.S. military is helping oil get out of the Persian Gulf on tankers, but Iran is still attacking the ships and scaring operators away.